To investigate the effect of COMMD3 expression on the clinical-pathological characteristics of HCC patients, we analyzed the relationship between clinical-pathological characteristics and COMMD3 mRNA level. This evidence concerns the gene COMMD3 and hepatocellular carcinoma.